Arkolith/Insider Trading/PCVX/Form 4

Pickering Grant

CHIEF EXECUTIVE OFFICER, DirectorVaxcyte, Inc. (PCVX) · full profile →Form 4 · filed Jun 19, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$1.3M
Net Open-Market Flow
-$1.3M
Transactions
6
5 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jun 18, 2026Option exercise(M)225$1.79$403497K
Jun 18, 2026Sell(S)225$52.51$12K497K
Jun 18, 2026Sell(S)22K$52.50$1.2M475K
Jun 18, 2026Sell(S)1K$52.50$53K135K
Jun 18, 2026Sell(S)1K$52.50$53K135K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jun 18, 2026Option exercise(M)225—$00

Transaction Codes

M
Option exercise / conversion
S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001258693-26-000010) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML